Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 22.2;Proximal tubular cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA					"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.3	1.2	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.3	0.5	0.1	7.3	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.8	0.0	4.1	0.3	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	5.6	0.1	0.8	0.4	1.5	1.2	0.0	0.0	0.0	0.1	2.1	0.6	0.2	2.8	11.7	0.8	0.0	29.2	4.4	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9	0.0	2.4	2.2	1.0	0.2	0.2	1.2	2.5	2.7	1.2	10.4	0.0	11.8	13.3	3.6	1.6	0.3	10.3	0.0	8.3	11.5	1.1	0.5	5.7	22.2	10.2	1.6	0.0	0.0	2.7	3.8	0.3	1.7	0.0	1.8	2.7	0.5	4.8	2.9	0.4	51.8	0.5	0.0	0.9	2.7	14.3	0.3	3.8	4.4	2.8	1.1
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell type enhanced"	"Detected in some"	21	"Hepatocytes: 2.4;Proximal tubular cells: 2.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"T-47d: 15.3"									HPA058258	Uncertain					NA	NA					"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.8	0.1	0.0	15.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 944.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	41.4	97.5	23.2	34.3	18.5	21.1	26.6	20.1	15.8	18.3	20.9	40.0	36.6	13.1	22.5	17.7	20.2	24.2	9.3	25.7	6.6	19.2	70.6	19.6	43.3	60.3	20.8	14.6	17.4	23.4	23.5	18.7	15.3	11.9	29.3	17.9	26.7	38.2	18.9	74.7	35.5	24.2	21.9	40.3	72.8	14.8	22.1	26.3	16.7	37.3	29.2	47.4	21.7	34.3	39.4	16.7	41.9	35.6	17.4	35.6	28.5	38.1	37.7	18.7	7.8	16.5	37.4	22.3	28.4	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3	119.1	121.6	108.7	168.5	132.0	55.6	277.3	203.8	155.2	153.6	188.5	19.6	436.4	442.7	236.1	329.1	152.3	247.2	186.9	293.4	435.1	217.2	291.4	105.2	427.2	386.6	31.8	182.7	139.3	155.4	944.1	168.2	179.2	248.0	315.6	205.6	112.3	274.1	235.0	154.9	400.2	53.7	103.5	220.7	379.1	245.5	163.2	425.4	121.6	237.2	254.5
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 745.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		470000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.1	0.0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1.0	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.8	0.4	89.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	745.7	0.0	0.0	0.0	11.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CINP	MGC849	ENSG00000100865	"Cyclin dependent kinase 2 interacting protein"	Q9BW66	14	102341102-102362916	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.47e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.71e-1)"	15.8	17.9	19.1	9.8	20.3	19.0	15.8	14.1	25.8	12.1	13.8	25.3	8.0	10.4	12.9	18.1	18.6	11.6	11.8	19.6	19.0	14.7	16.4	24.6	11.9	14.0	21.8	18.2	11.2	41.3	9.6	10.7	11.5	21.4	12.9	12.6	12.2	27.9	11.6	22.1	11.9	11.6	13.3	25.5	13.6	16.2	19.9	19.0	11.3	14.6	15.7	13.5	13.8	11.6	27.3	34.2	33.2	37.2	22.1	25.3	27.0	11.2	26.6	10.7	12.0	20.5	27.4	12.4	17.6	22.2	23.3	19.3	17.9	17.7	13.3	17.1	21.4	11.5	18.8	18.7	23.2	21.7	14.6	14.4	9.3	18.7	20.9	17.7	23.8	9.4	20.4	17.3	16.8	19.4	15.3	24.4	12.3	13.3	15.9	21.1	56.1	13.7	12.7	11.3	31.6	26.9	9.1	15.6	17.1	22.2	25.9	11.3	11.0	13.0	21.6	11.7	9.9	25.8	11.2	17.4	13.3	8.2	39.7	14.9	31.6	24.5	22.9	22.2	15.1	15.0	23.0	37.2	33.2	24.8	35.3	23.1	27.3	22.7	23.4	34.2	22.8	21.9	21.5	31.0	22.1	29.1	31.9	25.3	27.0	19.1	20.3	14.1	25.8	19.0	14.7	21.8	18.2	21.4	19.0	26.8	11.5	17.1	22.6	12.5	18.7	33.8	17.8	13.4	20.5	19.2	11.8	41.3	48.0	34.4	42.2	27.0	25.8	0.0	39.2	47.2	26.6	21.5	18.5	40.5	52.8	14.3	18.9	31.9	25.7	86.5	27.6	32.1	16.9	78.5	25.2	23.8	40.3	24.6	19.1	58.2	18.6	32.3	14.4	45.7	16.6	13.8	31.0	20.2	28.0	23.0
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.1	14.5	2.7	12.4	113.6	58.9	6.3	20.3	54.2	22.3	29.1	27.3	38.1	3.0	23.6	38.1	84.2	22.6	7.3	13.7	14.0	5.9	6.8	8.0	10.2	47.5	25.3	12.7	33.2	46.7	16.5	14.4	3.2	55.8	24.2	3.9	7.9	46.7	24.1	29.1	3.2	11.8	2.8	21.6	34.6	5.1	14.1	16.8	17.8	12.5	5.5	5.2	33.9	59.3	56.7	7.3	14.5	18.3	22.3	44.8	10.5	25.3	15.9	23.1	29.1	2.1	80.6	16.9	18.4	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2	32.8	24.6	40.4	31.0	21.5	54.2	10.9	58.6	22.7	26.1	68.0	56.9	86.8	33.2	172.8	2.3	41.6	257.8	0.0	146.8	91.1	44.1	21.0	9.2	53.3	279.4	44.5	51.9	105.0	166.6	3.6	30.5	81.3	106.3	136.1	70.2	92.8	127.7	92.2	25.8	168.1	30.9	25.8	46.4	6.2	32.4	19.9	120.5	54.2	85.6	31.9
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164583-32168281	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	4.5	6.3	7.3	2.6	7.6	4.5	5.0	6.3	9.4	7.1	6.7	8.4	8.7	4.7	6.4	5.5	4.3	4.8	8.4	4.8	8.2	4.4	4.3	1.8	4.3	2.0	25.7	3.9	14.4	2.9	1.3	2.9	9.2	14.1	6.0	2.7	14.7	3.9	5.3	3.8	12.9	5.8	3.0	11.9	3.5	3.9	2.3	7.0	0.2	3.1	8.3	2.0	5.2	6.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.3	1.3	3.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.2	0.0	0.0	2.0	1.3	0.4	0.0	0.0	1.9	0.0	1.0	3.6	1.1	0.0	0.7	0.0	0.3	0.3	0.0	0.1	0.7	2.2	0.3	0.0	0.0	1.7	1.0	3.0	0.0	0.3	0.0	1.1	0.1	0.0	0.2	0.6	0.5	1.2	0.0	0.1	3.7	0.0	1.4	2.2	0.0	0.8	1.7	0.0	0.1	0.0	0.1	0.1	0.1	1.1	1.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	7.6	6.3	9.4	8.2	4.4	25.7	3.9	14.1	7.0	6.0	5.5	0.0	0.6	1.3	1.4	0.1	0.0	2.7	2.3	1.8	2.0	0.7	0.0	0.2	0.1	1.0	0.0	0.0	0.2	0.3	0.8	0.6	0.0	0.0	0.2	0.0	0.0	2.5	0.3	0.0	3.4	0.0	0.0	0.0	1.0	1.1	0.2	0.0	1.1	0.0	1.1	0.0	1.2	0.4	0.4	1.9	0.7	0.0	1.2	0.4
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.2	0.0	0.0	0.0	6.4	0.2	0.5	9.9	17.0	0.0	0.0	0.0	0.0	0.6	17.5	0.0	11.7	0.0	16.4	0.0	10.1	0.1	0.2	12.5	0.5	0.2	2.7	0.1	0.0	7.6	0.0	0.6	0.0	0.5	0.6	0.0	0.2	0.0	6.4	0.1	2.1	0.0	9.6	8.9	17.8	0.0	0.0	0.1	4.5	5.1	0.0	0.0	4.1	9.5	2.0	5.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	5.1	0.0	0.0	0.0	27.5	1.6	0.0	4.8	8.6	0.7	0.0	0.0	0.8	17.8	7.2	2.1	0.0	13.2	1.1	0.0	0.0	0.0	0.0	12.4	0.9	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.4	0.0	10.2	19.4	0.3	12.1	7.9	0.0	1.4	0.0	0.0	0.0
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Cell line enhanced"	"Detected in many"		"JURKAT: 25.2;MOLT-4: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.5	6.7	7.4	5.6	5.4	1.0	3.4	3.8	2.9	6.4	0.9	0.0	0.0	0.6	4.7	12.1	0.7	8.6	4.8	2.2	0.0	11.2	0.2	1.4	0.0	5.2	2.6	1.0	4.4	1.8	3.0	3.1	4.2	4.8	25.2	0.0	0.0	6.1	1.1	19.2	0.0	6.4	0.0	3.5	0.0	9.6	0.0	0.1	0.0	8.9	2.6	3.7	5.9	1.0	4.8	2.3	0.2	0.4	1.3	2.6	2.0	2.6	4.5	8.9	0.0	3.1	0.0	2.0	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3	0.0	0.0	0.0	2.3	10.1	47.3	0.4	0.0	0.0	4.5	0.0	139.4	0.8	0.0	0.1	4.5	0.8	0.0	0.0	0.0	1.6	3.2	2.0	0.0	0.0	0.2	39.7	8.5	0.0	0.0	1.8	1.1	0.0	3.3	0.0	0.0	35.8	0.0	0.0	3.2	2.3	278.2	0.0	5.3	13.5	7.8	33.1	0.8	0.5	0.0	0.7
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 35.3;Hepatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6"	"Group enriched"	"Detected in many"	20	"NK-cells: 5.6;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA					"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"	7.6	9.8	7.7	7.9	9.4	3.7	7.9	10.9	12.3	4.0	14.5	8.6	0.9	11.8	3.4	2.7	16.6	2.9	11.1	8.1	6.6	5.9	6.4	43.9	3.3	2.2	7.5	9.4	2.0	2.5	10.6	7.1	2.6	15.7	3.0	14.1	4.3	6.9	3.2	1.4	12.3	10.2	5.7	20.0	1.9	16.9	1.3	7.3	1.1	2.3	7.9	4.0	6.0	5.0	0.1	0.0	0.2	0.1	5.6	4.9	0.8	13.4	8.0	29.3	7.3	19.7	20.7	15.0	9.4	4.6	3.3	7.4	3.9	23.7	1.1	0.8	7.2	11.3	12.6	22.2	27.5	7.7	4.6	6.4	15.2	8.7	10.2	12.2	14.8	9.9	18.0	6.4	16.8	8.0	10.9	6.5	1.6	18.1	31.5	7.3	7.1	3.4	1.5	13.4	8.2	4.8	2.3	11.5	3.9	21.4	10.1	5.2	11.2	4.8	32.0	4.1	13.9	5.4	0.1	2.4	6.7	7.9	11.2	11.4	1.5	4.9	24.9	10.2	0.0	1.7	0.2	0.1	0.1	4.8	0.0	4.9	0.1	2.1	3.2	0.0	0.1	0.7	2.3	0.2	5.6	0.0	0.0	0.2	0.8	7.7	9.4	10.9	12.3	6.6	5.9	7.5	9.4	15.7	7.3	0.0	5.6	0.0	2.3	1.5	22.3	2.4	7.6	1.4	6.8	10.4	35.3	1.2	5.0	6.1	3.7	1.1	16.0	0.0	7.3	21.6	3.9	2.4	5.8	43.3	1.6	25.4	2.9	4.3	2.7	2.7	1.1	0.7	0.0	0.0	12.4	4.4	12.1	24.6	1.1	5.6	15.9	6.5	3.8	0.2	1.2	6.0	1.7	12.8	12.4	4.4
FADS1	"D5D, FADS6, FADSD5, LLCDL1, TU12"	ENSG00000149485	"Fatty acid desaturase 1"	O60427	11	61799625-61829318	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 82.0;Rod photoreceptor cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042705	Approved					NA	NA					"HPA042705: AB_10795709"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.95e-9)"	"unprognostic (2.29e-2)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (2.79e-4)"	"prognostic unfavorable (1.33e-4)"	15.1	51.6	26.7	14.4	21.8	6.6	7.6	12.5	41.4	9.6	4.8	46.1	12.9	4.6	14.8	5.6	4.6	8.5	11.1	16.6	23.2	21.8	6.5	38.3	14.9	11.5	16.2	25.4	23.2	7.8	34.4	11.3	15.3	27.1	15.2	4.3	23.0	4.9	13.5	8.9	7.7	3.8	15.4	18.6	6.1	5.7	9.0	21.8	3.3	4.5	1.9	6.9	8.7	7.8	4.2	14.9	3.8	21.1	3.6	6.6	7.3	11.8	31.1	29.7	7.4	58.5	99.0	8.7	7.5	36.6	13.0	21.8	9.5	26.4	0.4	8.2	11.0	32.6	15.5	23.8	20.9	9.6	2.1	3.4	18.6	35.7	17.0	31.4	4.1	1.9	44.5	6.9	29.0	14.1	13.5	11.6	19.2	10.2	22.0	12.8	3.2	13.9	4.1	17.2	0.9	11.5	15.4	29.3	41.2	14.9	5.3	15.1	16.7	18.9	0.3	16.4	11.1	7.0	17.9	10.9	13.5	13.7	13.5	9.0	21.1	19.0	9.5	8.0	19.2	11.0	3.8	18.0	3.2	6.6	21.1	1.4	1.3	2.3	2.7	14.9	4.2	1.3	3.2	1.4	3.6	8.9	12.5	1.4	7.3	26.7	21.8	12.5	25.5	23.2	21.8	16.2	25.4	27.1	21.8	6.0	65.1	11.5	1.6	2.4	73.3	30.9	5.1	5.3	22.7	12.2	25.5	4.8	0.0	12.9	6.7	9.5	0.0	0.0	29.6	42.1	29.7	6.9	35.9	30.1	30.3	65.2	9.4	8.0	17.1	11.3	27.6	19.4	30.4	41.5	0.2	82.0	7.9	0.0	20.1	0.9	89.8	0.0	23.3	7.0	10.4	1.3	7.8	6.4	0.4	1.0
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 204.5;seminal vesicle: 98.8"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 34.3;Muller glia cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 151.3;HBEC3-KT: 90.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006741	Approved					NA	NA					"HPA006741: AB_1078796"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.21e-2)"	"unprognostic (8.95e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.42e-4)"	7.1	85.9	34.3	10.0	31.7	7.5	20.2	10.1	48.5	23.7	4.9	28.6	204.5	9.3	19.9	10.3	3.2	8.9	6.6	8.2	24.4	29.9	3.8	38.0	9.7	6.7	28.1	20.1	8.6	3.1	41.5	11.8	12.8	26.4	32.0	4.3	16.7	5.0	98.8	3.0	26.1	3.6	39.3	17.9	3.3	3.6	10.4	24.0	8.4	2.5	3.2	9.2	10.6	6.5	3.5	13.3	6.9	9.0	6.3	9.4	3.8	1.4	53.2	79.1	43.7	72.0	151.3	20.6	8.9	80.5	13.1	35.8	3.3	17.8	0.3	1.2	19.6	19.9	1.5	51.7	90.4	5.6	0.6	1.1	30.2	10.6	7.8	56.8	1.8	1.7	56.8	2.7	47.6	4.3	19.6	38.7	28.4	1.7	24.5	6.0	1.3	17.0	10.0	34.5	0.0	14.0	23.0	1.4	74.4	52.0	0.4	23.5	28.6	5.8	0.1	2.3	19.5	2.2	22.3	15.6	1.4	14.2	0.9	1.2	11.4	10.0	4.0	1.4	10.1	16.0	4.5	5.7	6.9	9.4	9.0	2.2	1.6	3.5	5.0	10.5	3.5	2.0	4.4	3.1	6.3	7.5	13.3	3.0	3.8	34.3	31.7	10.1	25.2	24.4	29.9	28.1	20.1	26.4	24.0	8.9	13.1	0.0	1.0	1.4	6.9	3.6	2.5	0.0	6.8	3.5	3.9	1.6	0.0	5.8	1.5	2.9	0.0	0.0	15.7	18.4	8.5	18.5	4.7	12.9	16.1	4.8	5.2	3.1	3.2	3.5	23.9	3.8	8.5	34.3	0.0	29.9	4.9	0.0	22.3	0.2	13.0	0.0	10.8	0.9	0.5	0.5	2.6	4.4	0.6	0.7
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 103.0;Hepatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 155.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.6	24.8	11.5	7.9	18.7	12.7	24.7	4.7	6.1	5.0	9.2	25.9	16.1	7.9	3.9	3.6	14.0	19.7	11.1	21.7	0.9	3.7	48.3	16.3	18.5	34.6	5.3	8.8	2.5	12.1	5.7	12.7	3.0	1.7	5.6	7.4	24.6	7.0	1.7	40.9	9.5	14.0	22.4	3.7	14.4	8.5	6.5	15.6	5.6	30.3	28.7	16.0	6.9	155.8	12.6	4.4	27.8	16.8	9.7	7.3	15.1	6.0	11.3	9.5	2.1	8.1	4.4	9.6	10.8	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8	23.8	103.0	0.8	10.3	6.9	24.9	4.8	25.5	6.7	10.3	10.4	5.9	28.9	3.3	18.9	1.2	4.5	20.8	23.3	24.9	65.8	10.4	65.5	12.7	169.2	11.7	28.6	17.4	11.1	6.9	1.3	15.3	5.0	16.9	8.2	18.9	12.3	16.1	17.5	10.6	5.5	9.5	0.0	9.6	1.9	13.9	12.0	24.7	10.7	18.3	17.5
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992321-29996436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	9.4	11.3	16.8	9.2	26.8	15.0	10.0	23.4	17.9	10.9	11.3	20.7	10.0	9.6	11.3	10.8	9.5	12.5	9.0	17.6	16.4	14.6	10.6	13.6	12.8	12.7	22.9	13.6	18.2	11.4	20.0	14.2	8.4	15.3	10.1	7.5	11.5	12.8	15.5	29.0	13.3	9.2	13.3	20.1	10.8	8.5	34.0	23.9	21.0	11.8	9.0	11.9	10.3	12.4	13.9	14.6	10.8	13.9	9.7	16.6	8.3	11.0	11.8	18.2	12.3	5.8	6.3	6.3	8.8	7.2	9.6	8.1	9.9	12.1	19.6	18.6	5.8	6.5	8.3	11.9	10.8	6.3	19.4	14.3	21.0	15.7	11.1	5.4	18.6	18.5	3.4	8.2	9.1	13.6	5.1	5.5	22.6	10.9	25.0	5.0	8.1	26.9	11.8	6.0	7.2	7.5	29.4	20.3	22.5	6.1	4.8	13.2	15.8	8.4	7.5	6.2	4.6	10.6	13.3	5.4	12.9	9.6	9.0	8.6	17.3	12.1	13.4	11.9	17.5	17.3	3.5	5.9	10.8	13.4	9.2	9.3	13.9	15.3	12.4	4.9	11.7	16.1	14.9	2.7	9.7	13.9	14.6	16.6	8.3	16.8	26.8	23.4	17.9	16.4	14.6	22.9	13.6	15.3	23.9	62.5	22.9	6.7	16.0	11.3	36.1	27.0	10.2	26.8	20.5	8.7	13.7	21.2	24.9	8.4	13.9	14.6	13.6	0.0	10.7	25.6	12.2	5.7	30.1	12.3	16.1	14.3	9.2	8.6	9.9	8.2	19.0	13.5	5.0	10.0	9.1	34.7	6.1	10.5	21.2	15.3	39.9	12.9	19.6	94.0	51.7	9.9	9.6	19.2	13.3	4.2
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
MCAT	"fabD, FASN2C, MCT, MCT1, MT, NET62"	ENSG00000100294	"Malonyl-CoA-acyl carrier protein transacylase"	Q8IVS2	22	43132206-43143394	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003122, HPA035471"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003122: AB_2666795, HPA035471: AB_10670590"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.86e-2)"	"prognostic favorable (2.18e-4)"	"prognostic favorable (3.89e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-1)"	10.4	18.2	13.3	8.2	17.2	11.0	12.8	10.4	24.6	10.6	11.9	9.4	10.7	9.5	11.0	17.2	12.3	20.7	21.4	12.9	14.4	14.2	25.6	24.3	8.6	7.1	12.0	12.0	14.4	16.2	20.3	14.3	9.2	15.1	12.8	10.6	9.9	14.5	10.2	17.7	11.7	9.7	8.6	6.0	7.6	12.1	19.6	5.2	18.4	20.1	14.0	9.9	8.5	8.1	10.2	13.9	2.5	9.5	11.6	10.3	5.6	7.2	9.5	6.8	11.8	5.7	6.1	6.9	8.1	7.2	11.0	10.2	9.5	7.4	12.2	8.4	6.0	6.2	12.2	12.8	10.7	8.2	4.2	37.8	4.5	11.0	10.5	9.1	21.6	5.5	4.5	10.5	10.7	8.5	6.4	7.8	7.4	10.7	5.0	5.3	13.3	10.0	23.5	6.5	10.2	16.9	13.3	6.6	19.3	13.7	6.3	8.9	4.7	8.7	17.1	12.3	3.2	8.8	14.0	4.6	4.8	9.4	10.3	11.4	8.9	9.2	8.8	10.3	8.3	5.7	0.0	9.5	0.7	7.7	9.1	10.3	8.3	8.6	10.1	13.9	10.2	10.1	7.1	2.5	11.6	5.5	13.7	5.5	5.6	13.3	17.2	10.4	24.6	14.4	14.2	12.0	12.0	15.1	5.2	6.0	5.0	6.7	9.1	15.9	10.0	8.7	30.6	10.7	4.5	19.2	0.0	16.7	43.1	25.8	13.8	7.1	10.0	0.0	19.0	8.4	9.3	14.1	3.5	20.8	13.6	6.4	13.9	16.5	8.2	9.0	6.9	4.8	6.8	8.2	12.4	9.5	19.8	17.5	15.6	67.4	8.7	19.4	9.8	29.0	10.4	18.3	7.7	4.9	22.7	9.5
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073852	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 61.3;testis: 24.0"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 347.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 3.6;thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 5.8;hTCEpi: 7.4;LHCN-M2: 5.6;SK-BR-3: 8.8;SuSa: 4.8;U-266/70: 4.9"									"HPA037947, HPA037948"	Enhanced					NA	NA					"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.0	1.1	0.2	0.2	0.7	1.2	5.2	0.3	0.7	0.8	0.5	0.3	0.1	0.0	0.2	0.4	2.7	1.4	1.1	0.8	0.2	0.2	0.8	0.4	1.9	4.3	0.9	0.1	0.2	0.1	0.1	1.5	61.3	0.4	0.1	0.0	0.3	3.0	0.1	0.5	0.4	0.3	0.1	0.5	8.0	0.2	24.0	0.3	0.2	1.2	0.1	0.3	0.3	1.1	0.5	1.1	6.6	0.4	1.0	0.6	0.1	0.2	0.6	0.7	0.5	0.3	1.1	2.2	0.4	0.4	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.2	0.7	0.4	0.2	0.3	0.4	0.0	0.9	0.0	0.6	5.8	7.4	0.9	0.1	0.1	0.7	0.2	0.5	0.3	5.6	0.0	0.5	0.7	0.7	0.2	0.4	0.7	1.3	1.8	0.0	0.0	0.0	0.4	0.3	8.8	0.1	4.8	0.2	0.5	1.0	0.1	2.9	1.3	0.1	4.9	1.6	0.4	2.7	0.5	0.0	1.4	0.4	0.4	0.4	0.2	0.3	0.2	0.6	0.2	0.2	0.5	0.3	0.3	6.6	1.0	0.2	1.1	0.4	0.1	0.2	0.7	0.3	0.3	0.2	0.2	0.9	0.1	0.4	0.3	3.0	1.1	0.0	0.2	0.2	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	347.4	0.0	0.0	0.0	0.0	1.4	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.2	35.4	4.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	7.8	0.0	0.7	6.5	0.4	1.7	1.7	0.3	9.5	0.5	0.0	0.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163680	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	8.5	13.1	10.4	9.3	10.6	3.0	9.6	21.9	11.8	16.1	10.5	13.1	11.7	15.8	13.8	14.9	13.7	14.2	10.6	12.3	10.7	7.5	17.8	13.1	14.3	6.6	12.2	7.7	25.1	7.0	3.1	7.7	14.3	9.8	10.5	9.6	16.1	7.2	11.4	19.1	30.9	6.9	10.4	7.1	11.8	15.2	6.4	11.5	11.5	7.4	13.2	8.1	13.9	12.0	0.2	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.8	0.0	4.8	1.6	2.6	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.0	1.2	1.3	0.0	7.4	0.0	0.4	1.0	8.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	7.0	0.2	13.3	10.4	0.0	0.4	0.0	0.0	6.0	0.0	0.0	0.5	7.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.4	0.0	10.4	10.6	21.9	11.8	10.7	7.5	12.2	7.7	9.8	11.5	0.0	0.3	0.0	2.7	3.0	12.0	5.8	2.5	0.0	3.4	3.5	15.7	11.6	1.7	1.4	0.2	4.6	1.3	0.0	2.6	7.8	4.8	1.0	0.0	3.9	2.4	3.2	4.7	4.9	1.5	1.0	3.7	1.4	6.8	0.0	2.9	7.5	1.3	3.4	2.8	2.3	5.2	0.0	4.7	3.1	4.5	1.9	19.5	1.3	2.8	1.3
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
